Advertisement

Advertisement

ERAS Stock Latest News

Erasca’s ERAS-601 Trial Completion: What Early Cancer Data Could Mean for Investors

Company AnnouncementsErasca’s ERAS-601 Trial Completion: What Early Cancer Data Could Mean for Investors

Erasca price target raised to $33 from $25 at JPMorgan

PremiumThe Fly

Erasca price target raised to $33 from $25 at JPMorgan

1M ago

Morning Movers: Regenxbio sinks following clinical hold on RGX-121

PremiumThe Fly

Morning Movers: Regenxbio sinks following clinical hold on RGX-121

1M ago

Erasca Wins FDA Fast Track for Pancreatic Therapy

PremiumCompany Announcements

Erasca Wins FDA Fast Track for Pancreatic Therapy

1M ago

Erasca granted Fast Track Designation for ERAS-0015

PremiumThe Fly

Erasca granted Fast Track Designation for ERAS-0015

1M ago

Erasca price target raised to $22 from $18 at H.C. Wainwright

PremiumThe FlyErasca price target raised to $22 from $18 at H.C. Wainwright

2M ago

Erasca price target raised to $21 from $20 at Guggenheim

The Fly

Erasca price target raised to $21 from $20 at Guggenheim

2M ago

Erasca price target raised to $20 from $18 at BofA

The Fly

Erasca price target raised to $20 from $18 at BofA

2M ago

Erasca reports Q2 EPS (14c), consensus (11c)

PremiumThe Fly

Erasca reports Q2 EPS (14c), consensus (11c)

2M ago

Erasca Bolsters R&D Leadership With New President Appointment

PremiumCompany Announcements

Erasca Bolsters R&D Leadership With New President Appointment

2M ago

Erasca price target raised to $21 from $12 at Morgan Stanley

PremiumThe Fly

Erasca price target raised to $21 from $12 at Morgan Stanley

2M ago

Erasca Announces Major Equity Offering to Fund Oncology

PremiumCompany Announcements

Erasca Announces Major Equity Offering to Fund Oncology

3M ago

Erasca price target raised to $24 from $21 at Jefferies

PremiumThe FlyErasca price target raised to $24 from $21 at Jefferies

3M ago

Erasca 31.429M share Spot Secondary priced at $17.50

The Fly

Erasca 31.429M share Spot Secondary priced at $17.50

3M ago

Erasca price target raised to $18 from $16 at BofA

The Fly

Erasca price target raised to $18 from $16 at BofA

3M ago

Analyst Maintains Buy Rating and $20 Price Target on Erasca as ERAS-0015 Data Bolster Foundational pan‑RAS Therapy Thesis

PremiumRatings

Analyst Maintains Buy Rating and $20 Price Target on Erasca as ERAS-0015 Data Bolster Foundational pan‑RAS Therapy Thesis

3M ago

Closing Bell Movers: Trex up 6% after positive Q2 pre-announcement

PremiumThe Fly

Closing Bell Movers: Trex up 6% after positive Q2 pre-announcement

3M ago

Erasca Reports Promising ERAS-0015 Data in Solid Tumors

PremiumCompany Announcements

Erasca Reports Promising ERAS-0015 Data in Solid Tumors

3M ago

Erasca $500M Spot Secondary being re-offered at $17.50

PremiumThe Fly

Erasca $500M Spot Secondary being re-offered at $17.50

3M ago

Erasca announces $500M common stock offering

PremiumThe FlyErasca announces $500M common stock offering

3M ago

Erasca files automatic mixed securities shelf

The Fly

Erasca files automatic mixed securities shelf

3M ago

Erasca announces updated preliminary ERAS-0015 data

The Fly

Erasca announces updated preliminary ERAS-0015 data

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >